Background: The management of the contralateral hip after unilateral
slipped capital femoral epiphysis is controversial. The purpose of this study
was to determine, with use of expected-value decision analysis, the optimal
management strategy—prophylactic in situ pinning versus
observation—for the contralateral hip.
Methods: Outcome probabilities were determined from a systematic
review of the literature. Utility values were obtained from a questionnaire on
patient preferences completed with use of a visual analog scale by twenty-five
adolescent male patients without slipped capital femoral epiphysis. A decision
tree was constructed, fold-back analysis was performed to determine the
optimal treatment, and one and two-way sensitivity analyses were performed to
determine the effect on decision-making of varying outcome probabilities and
utilities.
Results: Observation was the optimal management strategy for the
contralateral hip given the outcome probabilities and utilities that we
studied (the expected value was 9.5 for observation and 9.2 for prophylactic
in situ pinning, with a marginal value of 0.3). Increased rates of a late
second slip favored prophylactic in situ pinning (the threshold probability
was 27%). Risk-taking patients with a high utility for uncomplicated
prophylactic in situ pinning favored prophylaxis (the threshold utility was
9.8).
Conclusions: The iatrogenic risks of treating a healthy patient or
an uninvolved body part rarely outweigh the potential benefits unless the
probability of the adverse event is likely and the consequences of the adverse
event are very severe. In this decision analysis, the optimal decision was
observation. In cases where the probability of contralateral slipped capital
femoral epiphysis exceeds 27% or in cases where reliable follow-up is not
feasible, pinning of the contralateral hip is favored. For a given individual
patient, the optimal strategy depends not only on probabilities of the various
outcomes but also on personal preference. Thus, we advocate a model of
doctor-patient shared decision-making in which both the outcome probabilities
and the patient preferences are considered in order to optimize the
decision-making process.
Level of Evidence: Economic and decision analysis, Level
III-1 (limited alternatives and costs; poor estimates). See Instructions
to Authors for a complete description of levels of evidence.